ALS (amyotrophic lateral sclerosis) progresses through a general pattern: symptoms begin in one body region, spread to additional regions, and eventually affect breathing and nutrition. The average life expectancy after diagnosis is three to five years, though roughly 30% of people live five years or more, and 10% to 20% live at least a decade. While every person’s experience differs, the disease follows a recognizable trajectory that can be broken into early, middle, and late stages.
How ALS Onset Varies by Person
ALS doesn’t start the same way for everyone. There are two general types of onset: limb and bulbar. In limb-onset ALS, the first symptoms appear in the arms or legs. You might notice weakness, tripping or stumbling, or trouble with fine motor tasks like buttoning a shirt or turning a key. In bulbar-onset ALS, the earliest problems involve speaking or swallowing, often showing up as slurred speech or difficulty chewing.
Where symptoms begin matters because it shapes how the disease feels in its earliest phase and can influence the pace of progression. But regardless of where ALS starts, it eventually spreads to other regions of the body.
The Early Stage: One Region Affected
In the early stage, only one region of the body shows noticeable functional problems. This might mean weakness in one hand, a foot drop that causes stumbling, or subtle changes in speech clarity. Many people are still independent at this point. They can walk, eat, breathe, and communicate without assistance, even if certain tasks feel harder than they used to.
Because early symptoms can be subtle or easy to attribute to other causes, diagnosis often takes time. The gap between first symptoms and a confirmed diagnosis can stretch months or longer. During this stage, muscle twitching (fasciculations) and cramping are common, and muscles in the affected area may begin to visibly shrink.
The Middle Stage: Spreading to New Regions
The middle stage is defined by the disease spreading beyond its starting point. Weakness that began in a hand may now involve the opposite arm or a leg. Muscle atrophy becomes more widespread, and some muscles may become paralyzed entirely. Shortened muscles can prevent joints from fully straightening, a process called contracture.
Walking gets significantly harder during this period. Falls become more common, and if you fall, getting back up without help may not be possible. Driving is typically no longer safe. Daily activities like dressing, bathing, and eating increasingly require assistance from a caregiver or adaptive equipment.
Two major milestones often occur during the middle stage: swallowing problems and breathing difficulties.
Swallowing and Nutrition
Chewing and swallowing become increasingly difficult as the muscles controlling these functions weaken. The risk of choking rises, meals take longer, and maintaining adequate nutrition gets harder. At a certain point, many people need a feeding tube placed directly into the stomach to ensure they’re getting enough calories and fluids. In the King’s clinical staging system, a widely used framework for tracking ALS progression, reaching the point of needing a feeding tube is classified as Stage 4A.
Breathing Changes
ALS doesn’t damage the lungs themselves. Instead, it weakens the muscles responsible for breathing, including the diaphragm and the muscles between the ribs. As these muscles deteriorate, lung capacity drops. Early breathing symptoms include shortness of breath during activity, difficulty lying flat, daytime fatigue despite a full night’s sleep, and morning headaches or a foggy feeling upon waking. You might also notice frequent yawning or sighing during the day, or waking up multiple times at night.
A weakened cough reflex is another concern. When you can’t cough effectively, secretions pool in the lungs and throat, raising the risk of respiratory infections like pneumonia. As breathing muscles weaken further, non-invasive ventilation (a mask that helps push air into the lungs) becomes necessary. Reaching this point is classified as Stage 4B in the King’s system.
The Late Stage: Severe Functional Loss
In the late stage, most voluntary muscles are severely weakened or paralyzed. Communication becomes extremely difficult or impossible through natural speech, and most people rely on assistive technology such as eye-tracking devices. Mobility is gone, and full-time care is needed for virtually every daily function.
Breathing requires continuous support. Some people choose invasive ventilation through a surgically placed tube in the windpipe, which can extend survival but requires 24-hour care. Others opt for comfort-focused care. Respiratory failure is the most common cause of death in ALS.
One thing worth understanding: ALS primarily destroys motor neurons. The senses (sight, hearing, touch, taste, smell) typically remain intact, and for most people, thinking and awareness are preserved throughout, though a subset of patients do develop some cognitive changes.
Clinical Staging Systems
Doctors use formal staging systems to track where someone falls in the progression of ALS. Two of the most common are the King’s system and the Milano-Torino (MiToS) system.
The King’s system focuses on how many body regions are functionally involved:
- Stage 1: One region affected
- Stage 2: Two regions affected
- Stage 3: Three regions affected
- Stage 4A: Need for a feeding tube
- Stage 4B: Need for non-invasive ventilation
- Stage 5: Death
The MiToS system takes a different approach, measuring loss of function across four specific domains: walking and self-care, swallowing, communicating, and breathing. Stage 0 means no function has been fully lost in any domain. Stages 1 through 4 correspond to how many of those four domains have crossed the threshold into functional loss. Stage 5 is death.
These systems give clinicians a common language for describing disease progression and help in planning care. They also highlight something important about ALS: its stages aren’t defined by time but by functional milestones. Two people at the same stage may have arrived there on very different timelines.
Why Progression Speed Varies
ALS is sometimes called a nonlinear disease because it doesn’t always progress at a steady rate. Some people spend years in the early stage before the disease accelerates. Others experience rapid decline from the start. Bulbar-onset ALS tends to progress faster on average than limb-onset, though there are exceptions in both directions.
The three-to-five-year average survival figure is just that: an average. It includes people who live only a year or two alongside people who live a decade or more. Factors like age at onset, where symptoms begin, respiratory function at diagnosis, and nutritional status all influence the trajectory. Interventions like ventilation support and feeding tubes can meaningfully extend survival and improve quality of life at various stages.